Cargando…

Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients

OBJECTIVE: The objective of this study was to investigate the safety of robotic stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) patients and its related factors. METHODS: A total of 74 HCC patients with Child–Turcotte–Pugh (CTP) Class A were included in a multi-institut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaojie, Song, Yongchun, Liang, Ping, Su, Tingshi, Zhang, Huojun, Zhao, Xianzhi, Yuan, Zhiyong, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683791/ https://www.ncbi.nlm.nih.gov/pubmed/29158680 http://dx.doi.org/10.2147/OTT.S142025

Ejemplares similares

Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China
por: Zhao, Xianzhi, et al.
Publicado: (2020)

Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
por: Chen, Yi-Xing, et al.
Publicado: (2023)

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study
por: Zhu, Xiaofei, et al.
Publicado: (2020)

Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer
por: Xu, Bichun, et al.
Publicado: (2023)

Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer
por: Zhao, Xianzhi, et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
por: Roquette, Isaure, et al.
Publicado: (2022)

Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China
por: Zhao, Xianzhi, et al.
Publicado: (2021)

Phase I study of dose‐escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initial clinical results
por: Qing, Shuiwang, et al.
Publicado: (2021)

Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China
por: Xu, Chenyang, et al.
Publicado: (2022)

Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy
por: Lai, Lin, et al.
Publicado: (2020)

Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
por: Su, Ting-Shi, et al.
Publicado: (2016)

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma
por: Garg, Rashi, et al.
Publicado: (2020)

Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
por: Liang, Ping, et al.
Publicado: (2016)

Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival
por: Robbins, Jared R., et al.
Publicado: (2019)

A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
por: Sun, Kai, et al.
Publicado: (2022)

Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
por: Scher, Nathaniel, et al.
Publicado: (2019)

Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial
por: Zhao, Xianzhi, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
por: Yoon, Sang Min, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies
por: Schaub, Stephanie K., et al.
Publicado: (2018)

Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2021)

Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma
por: Shen, Jie, et al.
Publicado: (2017)

Safety and Efficacy of Stereotactic Body Radiation Therapy in the Treatment of Pulmonary Metastases from High Grade Sarcoma
por: Mehta, Niraj, et al.
Publicado: (2013)

Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases
por: Sogono, Paolo, et al.
Publicado: (2021)

Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial
por: Zhu, Xiaofei, et al.
Publicado: (2022)

Robotic stereotactic body radiation therapy for liver-limited malignant tumors
por: Frączek, Mariusz, et al.
Publicado: (2014)

Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular Carcinoma
por: Wang, Lei, et al.
Publicado: (2018)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma
por: Zhang, Tao, et al.
Publicado: (2018)

Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
por: Gerum, Sabine, et al.
Publicado: (2019)

Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity
por: Lewis, Shirley, et al.
Publicado: (2022)

The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
por: Kimura, Tomoki, et al.
Publicado: (2022)

Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2015)

Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy
por: Jiang, Xiao-Yan, et al.
Publicado: (2021)

Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open‐Label, Phase Ib Study
por: Lin, Chia‐Chi, et al.
Publicado: (2020)

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy
por: Zhu, Xiaofei, et al.
Publicado: (2021)

Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary
por: Solberg, Timothy D., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_js10c99il3jg3bp52i2km77ds4